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Résumé en
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PURPOSE: Although some specific genetic syndromes such as neurofibromatosis
(NF) have been identified as risk factor of childhood brain tumors (CBT), the
potential role of inherited susceptibility in CBT has yet to be elucidated.
METHODS: To further investigate this, we conducted a pooled analysis of two
nationwide case-control studies ESCALE and ESTELLE. The mothers of 509 CBT
cases and 3,102 controls aged under 15 years who resided in France at
diagnosis/interview, frequency-matched by age and gender, responded to a
telephone interview conducted by trained interviewers. Pooled odds ratio (OR) and
95% confidence intervals (95% CI) were estimated using unconditional logistic
regression.
RESULTS: CBT was significantly associated with the family history of cancer in
relatives (OR 1.2, 95% CI 1.0-1.5). The OR was slightly higher for maternal relatives
than for paternal relatives, and when at least two relatives had a history of cancer.
CBT was significantly associated with a family history of brain tumor (OR 2.1, 95%
CI 1.3-3.7). This association seemed stronger for first-degree relatives (mother,
father, and siblings), for whom, by contrast, no association was seen for cancers
other than CBT. No specificity by CBT subtypes or by age of the children were found
for any of these findings.
CONCLUSION: Our findings support the hypothesis of a familial susceptibility of
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